About: Medicus Pharma Ltd., a biotech/life sciences company, focuses on developing clinical development programs of therapeutic assets in the United States. It is developing SKNJCT-003, which is in Phase 2 study for the treatment of basal cell carcinoma of the skin. The company has a strategic collaboration with the Gorlin Syndrome Alliance to access to SKINJECT in Patients with Gorlin Syndrome. The company was formerly known as Interactive Capital Partners Corporation and changed its name to Medicus Pharma Ltd. in September 2023. The company was incorporated in 2008 and is headquartered in West Conshohocken, Pennsylvania.
Sector: Healthcare
Industry: Drug Manufacturers - General
Latest price: $1.88 (-7.39%)
MDCX NASDAQ Medicus Pharma Ltd. Common Stock
Medicus Pharma Ltd. Common Stock share price
Atividade de preço de MDCX
Último preço
$ 1,880
Variação (24h)
-0,15 USD (7,39%)
Volume
233.73K
Volume (média 4 sem.)
-
Abertura
$ 2,12
Variação do dia
$ 1,71 - $ 2,16
Fechamento anterior
$ 2,03
Último negócio
04 Nov, 9:00 pm GMT+0
Atrasado
04 Nov, 9:00 pm GMT+0
MDCX price performance
Atrasado
04 Nov, 9:00 pm GMT+0
MDCX details
quote.marketSignals